{
  "id": "multiple-myeloma-regimen-margins",
  "display_name": "Multiple Myeloma Margin Components",
  "cohort": "Multiple Myeloma, RRMM, Regimen Margin Components (2024–2025)",
  "insight_type": "Margin Component Analysis",
  "summary": "Dara-Rd regimen delivers 82% higher net margins vs. Rd due to optimal payer mix, higher reimbursement rates, and operational efficiencies despite higher drug costs.",
  "chart": {
    "type": "bar",
    "unit": "component",
    "data": [
      { "name": "Drug Acquisition", "value": -22, "gap": -22, "highlight": true },
      { "name": "Admin Costs", "value": -5, "gap": -5, "highlight": false },
      { "name": "Reimbursement", "value": 87, "gap": 87, "highlight": false },
      { "name": "Supportive Care", "value": -8, "gap": -8, "highlight": false },
      { "name": "Patient Cost Share", "value": 12, "gap": 12, "highlight": false },
      { "name": "Net Margin", "value": 64, "gap": 64, "highlight": true }
    ],
    "benchmark": 0,
    "nccn_target": 0
  },
  "financial_impact": {
    "annual_opportunity": "$385,000/year",
    "math": "$385,000/year = $73,000 margin difference × 35 additional patients × 15% utilization increase"
  },
  "clinical_impact": {
    "description": "Balancing financial margins with clinical outcomes is essential for sustainable care delivery.",
    "metrics": [
      {
        "type": "PFS",
        "value": "+18.4 months",
        "description": "Superior PFS with Dara-Rd vs. Rd alone"
      },
      {
        "type": "OS",
        "value": "+13.3 months",
        "description": "Overall survival benefit"
      },
      {
        "type": "ORR",
        "value": "+31%",
        "description": "Higher objective response rate"
      },
      {
        "type": "QoL",
        "value": "+24%",
        "description": "Improved quality of life scores"
      },
      {
        "type": "ToT",
        "value": "+52%",
        "description": "Longer time on treatment"
      }
    ],
    "quantitative": "+18.4 months PFS"
  },
  "peer_comparison": {
    "description": "Top-performing practices achieve 8% higher net margins on Dara-Rd than your practice through optimized billing practices and improved payer contracts.",
    "peer_benchmark": 72,
    "financial_impact": {
      "annual_opportunity": "$580,000/year",
      "math": "$580,000/year = $8,000 additional margin × 73 patients"
    },
    "action_steps": [
      {
        "text": "Analyze top performer billing and contract strategies",
        "icon": "chart-line"
      },
      {
        "text": "Implement optimized billing workflow for Dara-based regimens",
        "icon": "document"
      },
      {
        "text": "Renegotiate payer contracts for Daratumumab reimbursement",
        "icon": "users"
      },
      {
        "text": "Develop waste minimization protocols for high-cost drugs",
        "icon": "clipboard"
      }
    ]
  },
  "weighted_score": 95,
  "action_steps": [
    {
      "text": "Create standardized Dara-Rd administration protocols",
      "icon": "document"
    },
    {
      "text": "Implement waste reduction strategy for Daratumumab",
      "icon": "clipboard"
    },
    {
      "text": "Develop patient-specific financial navigation",
      "icon": "users"
    },
    {
      "text": "Analyze payer-specific reimbursement rates",
      "icon": "chart-line"
    }
  ],
  "suggestions": [
    {
      "text": "Optimize administration scheduling to maximize chair utilization",
      "icon": "document"
    },
    {
      "text": "Evaluate dosing strategies to minimize waste",
      "icon": "chart"
    }
  ],
  "drilldowns": [
    {
      "label": "View by Provider",
      "cohort": "Multiple Myeloma Regimen Selection by Provider",
      "jsonFile": "multiple-myeloma-by-provider.json",
      "drilldownLevel": 1
    },
    {
      "label": "View by Payer",
      "cohort": "Multiple Myeloma Regimen Selection by Payer",
      "jsonFile": "multiple-myeloma-by-payer.json",
      "drilldownLevel": 1
    },
    {
      "label": "Compare Sites",
      "cohort": "Multiple Myeloma Regimen Selection by Site",
      "jsonFile": "multiple-myeloma-by-site.json",
      "drilldownLevel": 1
    }
  ]
} 